MIRA INFORM REPORT

Report No. :	324212
Report Date :	26.05.2015

IDENTIFICATION DETAILS

Name :	BLUE CROSS LABORATORIES PRIVATE LIMITED (w.e.f 15.05.2015)
Formerly Known As :	BLUE CROSS LABORATORIES LIMITED
Registered Office :	Peninsula Chambers, Peninsula Corporate Park, Ganpatrao Kadam Marg, Lower Parel (West), Mumbai – 400013, Maharashtra
Tel. No.:	91-95253-2382617
Country :	India
Financials (as on) :	31.03.2014
Date of Incorporation :	09.07.1980
Com. Reg. No.:	11-022825
Capital Investment / Paid-up Capital :	Rs. 162.000 Million
CIN No.: [Company Identification No.]	U24230MH1980PTC022825
TAN No.: [Tax Deduction & Collection Account No.]	Not Available
PAN No.: [Permanent Account No.]	Not Available
Legal Form :	Private Limited Liability Company
Line of Business :	Manufacturer and Supply of Pharmaceuticals.
No. of Employees :	Information declined by the management

RATING & COMMENTS

MIRA’s Rating :

A (64)

RATING		STATUS	PROPOSED CREDIT LINE
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large

Maximum Credit Limit :	USD 8400000
Status :	Good
Payment Behaviour :	Regular
Litigation :	Clear
Comments :	Subject is an established company having good track record. Financial position of the company is sound. Fundamentals of the company are strong and healthy. Trade relations are reported as fair. Business is active. Payment terms are reported to be regular and as per commitment. The company can be considered normal for business dealings t usual trade terms and conditions.

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – March 31, 2015

Country Name	Previous Rating (31.12.2014)	Current Rating (31.03.2015)
India	A1	A1

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

EXTERNAL AGENCY RATING

Rating Agency Name	Not Available
Rating	Not Available
Rating Explanation	Not Available
Date	Not Available

RBI DEFAULTERS’ LIST STATUS

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

INFORMATION DENIED

Management Non-cooperative (91-22-66638000)

LOCATIONS

Registered Office / Corporate Office :	Peninsula Chambers, Peninsula Corporate Park, Ganpatrao Kadam Marg, Lower Parel (West), Mumbai – 400013, Maharashtra, India
Tel. No.:	91-253-2382617
Fax No.:	91-253-2381259
E-Mail :	suresh@bluecrosslabs.com info@bluecrosslabs.com
Website :	www.bluecrosslabs.com

DIRECTORS

As on 28.06.2014

Name :

Mr. Nihchal Hemandas Israni

Designation :

Director

Address :

5E Navroze Apartments, Bhulabhai Desai Road, Mumbai – 400026, Maharashtra, India

Date of Birth/Age :

07.06.1929

Date of Appointment :

01.02.2010

PAN No.:

AAAPI0223R

DIN No.:

00038328

Other Directorship:

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U24230MH1980PLC022825	BLUE CROSS LABORATORIES LIMITED	Director	01/02/2010	09/07/1980	-	Active	NO
2	U24230MH1983PTC029606	GOLD CROSS LABORATORIES PRIVATE LIMITED	Director	23/03/1983	23/03/1983	-	Active	NO
3	U74140MH1990PTC055266	NIKO MANAGEMENT SERVICES PRIVATE LIMITED	Director	05/06/1990	05/06/1990	-	Active	NO
4	U24230MH1992PTC069732	EVEREST HERBAL PRODUCTS PRIVATE LIMITED	Director	26/11/1992	26/11/1992	-	Strike off	NO
5	U85190MH1989PTC053052	HARIMAN LABORATORIES PRIVATE LIMITED	Whole-time director	01/07/2009	01/07/2006	-	Active	NO
6	U85199KA2007PTC042912	AGADI SUNRISE HOSPITAL PRIVATE LIMITED	Director	08/07/2007	08/07/2007	30/07/2009	Active	NO

Name :

Mr. Manoj Nihchal Israni

Designation :

Managing director

Address :

314, Samudra Mahal 14^th Floor, Worli, Mumbai – 400018, Maharashtra, India

Date of Birth/Age :

24.08.1968

Date of Appointment :

01.01.2010

PAN No.:

AAAPI0224J

DIN No.:

00038362

Other Directorship:

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U74140MH1990PTC055266	NIKO MANAGEMENT SERVICES PRIVATE LIMITED	Director	14/02/1991	14/02/1991	-	Active	NO
2	U24230MH1992PTC069732	EVEREST HERBAL PRODUCTS PRIVATE LIMITED	Director	26/11/1992	26/11/1992	-	Strike off	NO
3	U24230MH1980PLC022825	BLUE CROSS LABORATORIES LIMITED	Managing director	01/01/2010	05/01/1995	-	Active	NO
4	U24230MH1983PTC029606	GOLD CROSS LABORATORIES PRIVATE LIMITED	Director	06/08/1998	06/08/1998	-	Active	NO
5	U85190MH1989PTC053052	HARIMAN LABORATORIES PRIVATE LIMITED	Director	06/04/2006	06/04/2006	-	Active	NO
6	U74999MH2012PTC231037	MERCURY ADVISORS PRIVATE LIMITED	Director	15/05/2012	15/05/2012	-	Active	NO

Name :

Mr. Bhalchandra Govind Barve

Designation :

Managing Director

Address :

B-101, Bhagirathi Nivas, M V Road, Andheri (East), Mumbai – 400069, Maharashtra, India

Date of Birth/Age :

21.06.1959

Date of Appointment :

01.01.2010

PAN No.:

AFXPB9167P

DIN No.:

00038468

Other Directorship:

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U24230MH1983PTC029606	GOLD CROSS LABORATORIES PRIVATE LIMITED	Director	15/05/1996	15/05/1996	-	Active	NO
2	U24230MH1980PLC022825	BLUE CROSS LABORATORIES LIMITED	Managing director	01/01/2010	18/05/1998	-	Active	NO
3	U24230MH1992PTC069732	EVEREST HERBAL PRODUCTS PRIVATE LIMITED	Director	16/05/2000	16/05/2000	-	Strike off	NO
4	U85190MH1989PTC053052	HARIMAN LABORATORIES PRIVATE LIMITED	Director	03/03/2001	03/03/2001	-	Active	NO
5	U74140MH1990PTC055266	NIKO MANAGEMENT SERVICES PRIVATE LIMITED	Director	27/06/2011	07/07/2010	-	Active	NO
6	U22219MH2007PTC166876	ROHIT ARTS PRIVATE LIMITED	Director	01/09/2011	01/09/2011	-	Active	NO

Name :

Mr. Satyanarayain R Agarwala

Designation :

Director

Address :

62 Ashoka Apartments, 68 Napeansea Road, Mumbai – 400006, Maharashtra, India

Date of Birth/Age :

15.05.1934

Date of Appointment :

17.01.2007

DIN No.:

00036079

Other Directorship:

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U74999MH1994PTC077121	CLIPHAMED CONSULTANTS PRIVATE LIMITED	Director	16/03/1994	16/03/1994	-	Active	NO
2	L24390MH1976PLC019380	J B CHEMICALS AND PHARMACEUTICALS LIMITED	Director	25/07/2011	08/03/2002	-	Active	NO
3	U24230MH1980PLC022825	BLUE CROSS LABORATORIES LIMITED	Director	17/01/2007	17/01/2007	-	Active	NO
4	U51397MH2008PTC181835	ONCORX PHARMA PRIVATE LIMITED	Director	01/05/2008	01/05/2008	-	Active	NO

Name :

Mr. Jagdish Sriram Gilda

Designation :

Whole Time Director

Address :

Sukh Shanti B-Flat No.10, Anand Nagar, Off Gangapur, Road, Near Akashwani, Nashik – 420018, Maharashtra, India

Date of Birth/Age :

24.03.1954

Date of Appointment :

01.02.1997

PAN No.:

ABLPG7716M

DIN No.:

00036625

Other Directorship:

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U24230MH1980PLC022825	BLUE CROSS LABORATORIES LIMITED	Whole-time director	01/02/1997	01/02/1997	-	Active	NO
2	U24230MH1992PTC069732	EVEREST HERBAL PRODUCTS PRIVATE LIMITED	Director	21/10/2000	21/10/2000	-	Strike off	NO

Name :

Mr. Rohit Jayaramdas Patel

Designation :

Director

Address :

91 Devi Bhavan 38 nepeansea Road, Mumbai – 400036, Maharashtra, India

Date of Birth/Age :

26.06.1939

Date of Appointment :

04.07.2008

DIN No.:

00270126

Other Directorship:

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	L21010MH1960PLC011764	CITADEL REALTY AND DEVELOPERS LIMITED	Managing director	26/07/1960	26/07/1960	27/06/2008	Active	NO
2	U74900MH1969PTC014308	JMP TRADING AND PROPERTIES PRIVATE LIMITED	Director	12/06/1969	12/06/1969	-	Active	NO
3	U74999MH1966PLC013452	NEW CHEMI INDUSTRIES LIMITED	Director	30/09/2009	27/08/1971	17/12/2010	Amalgamated	NO
4	U65990MH1972PTC015604	SONIKA INVESTMENTS PRIVATE LIMITED	Director	10/12/1972	10/12/1972	08/11/2012	Active	NO
5	U22122GJ1972PTC002124	TRIWAL BOARD PRIVATE LIMITED	Director	04/03/1974	04/03/1974	-	Active	NO
6	U65990MH1974PTC017612	ROHIT INVESTMENTS PRIVATE LIMITED	Director	15/07/1974	15/07/1974	-	Active	NO
7	U24231GJ1978PTC003250	SCOTT PHARMACEUTICALS PRIVATE LIMITED	Director	21/12/1978	21/12/1978	17/12/2010	Amalgamated	NO
8	U22122GJ1980PTC003860	MULTI PACK SYSTEMS PRIVATE LIMITED	Director	29/07/1980	29/07/1980	-	Active	NO
9	U29199GJ1961PTC034038	VFC INDUSTRIES PRIVATE LIMITED	Director	31/07/1984	31/07/1984	-	Active	NO
10	U51900MH1984PTC032047	GANGOTRI TRADING COMPANY PRIVATE LIMITED	Director	09/11/1985	09/11/1985	-	Active	NO
11	U65990MH1978PTC020225	SHEFALI INVESTMENTS PRIVATE LIMITED	Director	05/03/1991	05/03/1991	-	Active	NO
12	U51900MH1997PTC111376	KEYUR TRADING COMPANY PRIVATE LIMITED	Director	17/10/1997	17/10/1997	-	Active	NO
13	U51109MH1998PTC113841	RISHIKESH AGENCIES PRIVATE LIMITED	Director	09/03/1998	09/03/1998	-	Active	NO
14	U01110MH1987PTC044936	SC ENVIRO AGRO INDIA PRIVATE LIMITED.	Director	29/09/2003	29/09/2003	17/12/2010	Amalgamated	NO
15	U24230MH1980PLC022825	BLUE CROSS LABORATORIES LIMITED	Director	04/07/2008	05/12/2007	-	Active	NO

Name :

Mr. Ashish Mangesh Shirsat

Designation :

Whole-time director

Address :

B-26, Home CHS, Releif Road, Daulat Nagar, Santacruz, Mumbai – 400054, Maharashtra, India

Date of Birth/Age :

27.07.1970

Date of Appointment :

01.09.2006

DIN No.:

00686815

Name :

Mr. Rajendra Yashwant Padhye

Designation :

Director

Address :

9 Bharat Apartments, 2^nd Floor, Plot 187, Garodia Nagar, Ghatkoper (E), Mumbai – 400077, Maharashtra, India

Date of Birth/Age :

30.12.1945

Date of Appointment :

11.07.2011

DIN No.:

00021000

Other Directorship:

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U85190MH1989PTC053052	HARIMAN LABORATORIES PRIVATE LIMITED	Director	07/09/1989	07/09/1989	-	Active	NO
2	U24230MH1980PLC022825	BLUE CROSS LABORATORIES LIMITED	Director	11/07/2011	20/03/2001	-	Active	NO
3	U74140MH1990PTC055266	NIKO MANAGEMENT SERVICES PRIVATE LIMITED	Director	27/06/2011	07/07/2010	-	Active	NO

KEY EXECUTIVES

Name :	Mr. Suresh Mahalingam
Designation :	Secretary
Address :	B 5/4, Sukumar Chs Limited, Dayaldas Road, Vile Parle (East), Mumbai – 400057, Maharashtra, India
Date of Birth/Age :	25.10.1967
Date of Appointment :	14.02.2005
PAN No.:	AFFPM9318H
Name :	Ketki Raj Wadhawa
Designation :	CFO
Address :	1203, Bhairav Darshan, Elephinstone, Mumbai – 400013, Maharashtra, India
Date of Birth/Age :	09.03.1968
Date of Appointment :	05.06.2014
PAN No.:	AADPC5841N

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

As on 28.06.2014

Names of Shareholders	No. of Shares
Nichal Israni	2824006
Haresh ISrani	3524479
Manoj Israni	3519082
Bhalchandra Barve	41300
Ashish Shirsat	35000
Jagdish Gilda	30000
Anup Kumar Burman	21000
Niko Management Services Private Limited, India	127500
Hariman Laboratories Private Limited, India	3034740
Rohit Patel	972000
Neeta Patel	195000
Renuka Patel	168000
Bina Patel	690000
Sraoj Gehani	405000
Puran Gehani	567000
Satyanarain Agarwala	10893
Rajendra PAdhye	5000
Suresh Mahalingam	5000
Ketki Wadhwa	5000
Kiran Daholkar	5000
Leela Agarwala	5000
Sarojini Bhojwani	10000
Total	16200000

Equity Share Break up (Percentage of Total Equity)

As on

Category	Percentage
Bodies corporate	19.52
Directors or relatives of Directors	74.20
Other top fifty shareholders	6.28
Total	100.00

BUSINESS DETAILS

Line of Business :

Manufacturer and Supply of Pharmaceuticals.

Products :

Item Code No.	Product Description
3003	Medicaments (Excl Goods Hdg No 3002 3005 Or 3 0 0 6 ) Cnsistnc Of Two/More Constunts Mxd Together For Hmn Medcne Nt FR RTL SALE
30031000	T U S Q X Liq,Meaftalspas And Tusq DX Lip

Brand Names :

Not Divulged

Agencies Held :

Not Divulged

Exports :

Not Divulged

Imports :

Not Divulged

Terms :

Not Divulged

PRODUCTION STATUS NOT AVAILABLE

GENERAL INFORMATION

Suppliers :

Reference :	Not Divulged
Name of the Person :	Not Divulged
Contact No.:	Not Divulged
Since How Long Known :	Not Divulged
Maximum Limit Dealt :	Not Divulged
Experience :	Not Divulged
Remark:	Not Divulged

Customers :

Reference :	Not Divulged
Name of the Person :	Not Divulged
Contact No.:	Not Divulged
Since How Long Known :	Not Divulged
Maximum Limit Dealt :	Not Divulged
Experience :	Not Divulged
Remark:	Not Divulged

No. of Employees :

Information declined by the management

Bankers :

• Central Bank of India (Lead Bank ), Chandermukhi Building, Ground Floor, Nariman Point, Mumbai - 400021, Maharashtra, India

Facilities :

(Rs. In Million)

SECURED LOAN	As on 31.03.2014	As on 31.03.2013
SHORT TERM BORROWING
Other Loans and Advances	120.288	136.913
Total	120.288	136.913

Banking Relations :	--
Auditors :
Name :	B. S. Mehta Company Chartered Accountants
Address :	11/13, Botawala Building, 2^nd Floor, Horiman Circle, Mumbai – 400001, Maharashtra, India
PAN N Income-tax PAN of auditor or auditor's firm :	AAAPI1800Q
Memberships :	Not Available
Collaborators :	Not Available
Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives:	· Rohit Arts Private Limited, India CIN: U22219MH2007PTC166876 · Niko Management Services Private Limited, India CIN: U74140MH1990PTC055266 · Hariman Laboratories Private Limited, India CIN: U85190MH1989PTC053052

CAPITAL STRUCTURE

As on 31.03.2014

Authorised Capital :

No. of Shares	Type	Value	Amount
35,000,000	Equity Shares	Rs.10/- each	Rs. 350.000 Million

Issued, Subscribed & Paid-up Capital :

No. of Shares	Type	Value	Amount
16,200,000	Equity Shares	Rs.10/- each	Rs.162.000 Million

FINANCIAL DATA

[all figures are in Rupees Million]

ABRIDGED BALANCE SHEET

SOURCES OF FUNDS	31.03.2014	31.03.2013	31.03.2012
I.              EQUITY AND LIABILITIES
(1)Shareholders' Funds
(a) Share Capital	162.000	108.000	108.000
(b) Reserves & Surplus	2767.254	2654.021	2249.738
(c) Money received against share warrants	0.000	0.000	0.000
(2) Share Application money pending allotment	0.000	0.000	0.000
Total Shareholders’ Funds (1) + (2)	2929.254	2762.021	2357.738
(3) Non-Current Liabilities
(a) long-term borrowings	0.770	4.275	4.920
(b) Deferred tax liabilities (Net)	7.464	7.360	8.336
(c) Other long term liabilities	20.573	19.177	0.683
(d) long-term provisions	32.966	35.588	33.452
Total Non-current Liabilities (3)	61.773	66.400	47.391
(4) Current Liabilities
(a) Short term borrowings	120.288	136.913	106.376
(b) Trade payables	218.352	170.416	130.557
(c) Other current liabilities	205.293	143.326	186.196
(d) Short-term provisions	198.010	21.552	23.994
Total Current Liabilities (4)	741.943	472.207	447.123
TOTAL	3732.970	3300.628	2852.252
II.          ASSETS
(1) Non-current assets
(a) Fixed Assets
(i) Tangible assets	264.731	265.417	227.068
(ii) Intangible Assets	9.972	10.385	8.268
(iii) Capital work-in-progress	12.479	0.030	7.804
(iv) Intangible assets under development	0.000	0.000	0.000
(b) Non-current Investments	0.010	0.010	0.010
(c) Deferred tax assets (net)	0.000	0.000	0.000
(d) Long-term Loan and Advances	12.120	11.584	15.506
(e) Other Non-current assets	296.804	347.143	112.436
Total Non-Current Assets	596.116	634.569	371.092
(2) Current assets
(a) Current investments	300.000	60.000	120.000
(b) Inventories	375.438	326.384	285.558
(c) Trade receivables	260.073	220.257	190.332
(d) Cash and cash equivalents	2056.832	1925.224	1728.472
(e) Short-term loans and advances	39.303	30.120	33.265
(f) Other current assets	105.208	104.074	123.533
Total Current Assets	3136.854	2666.059	2481.160
TOTAL	3732.970	3300.628	2852.252

PROFIT & LOSS ACCOUNT

	PARTICULARS	31.03.2014	31.03.2013	31.03.2012
	SALES
	Income	3945.234	3541.644	3185.437
	Other Income	238.490	210.756	154.162
	TOTAL (A)	4183.724	3752.400	3339.599
Less	EXPENSES
	Cost of Materials Consumed	622.190	554.491	506.335
	Purchases of Stock-in-Trade	998.340	865.664	702.635
	Changes in inventories of finished goods, work-in-progress and Stock-in-Trade	(34.702)	(38.870)	(5.385)
	Employees benefits expense	588.918	537.003	484.501
	Other expenses	754.876	644.552	564.615
	TOTAL (B)	2929.622	2562.840	2252.701
Less	PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (C)	1254.102	1189.560	1086.898
Less	FINANCIAL EXPENSES (D)	4.777	3.796	2.776
	PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E)	1249.325	1185.764	1084.122
Less/ Add	DEPRECIATION/ AMORTISATION (F)	45.832	43.589	36.496
	PROFIT/ (LOSS) BEFORE TAX (E-F) (G)	1203.493	1142.175	1047.626
Less	TAX (H)	404.486	361.331	333.948
	PROFIT/ (LOSS) AFTER TAX (G-H) (I)	799.007	780.844	713.678
	EARNINGS IN FOREIGN CURRENCY	190.700	176.400	152.900
	Earnings / (Loss) Per Share (Rs.)	49.32	72.3	66.08

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

Particulars	31.03.2014	31.03.2013	31.03.2012
Current Maturities of Long term debt	NA	NA	NA
Cash generated from operations	NA	NA	NA

KEY RATIOS

PARTICULARS		31.03.2014	31.03.2013	31.03.2012
Net Profit Margin (PAT / Sales)	(%)	20.25	22.05	22.40
Operating Profit Margin (PBIDT/Sales)	(%)	31.79	33.59	34.12
Return on Total Assets (PBT/Total Assets}	(%)	32.35	34.61	36.83
Return on Investment (ROI) (PBT/Networth)		0.41	0.41	0.44
Debt Equity Ratio (Total Debt /Networth)		0.04	0.05	0.05
Current Ratio (Current Asset/Current Liability)		4.23	5.65	5.55

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

DEBT EQUITY RATIO

Particular	31.03.2012	31.03.2013	31.03.2014
	(Rs. In Million)	(Rs. In Million)	(Rs. In Million)
Share Capital	108.000	108.000	162.000
Reserves & Surplus	2249.738	2654.021	2767.254
Money received against share warrants	0.000	0.000	0.000
Share Application money pending allotment	0.000	0.000	0.000
Net worth	2357.738	2762.021	2929.254
long-term borrowings	4.920	4.275	0.770
Short term borrowings	106.376	136.913	120.288
Total borrowings	111.296	141.188	121.058
Debt/Equity ratio	0.047	0.051	0.041

YEAR-ON-YEAR GROWTH

Year on Year Growth	31.03.2012	31.03.2013	31.03.2014
	(Rs. In Million)	(Rs. In Million)	(Rs. In Million)
Sales	3185.437	3541.644	3945.234
		11.182	11.396

NET PROFIT MARGIN

Net Profit Margin	31.03.2012	31.03.2013	31.03.2014
	(Rs. In Million)	(Rs. In Million)	(Rs. In Million)
Sales	3185.437	3541.644	3945.234
Profit	713.678	780.844	799.007
	22.40%	22.05%	20.25%

LOCAL AGENCY FURTHER INFORMATION

Sr. No.	Check list by info agents	Available in Report (Yes/No)
1	Year of establishment	Yes
2	Constitution of the entity -Incorporation details	Yes
3	Locality of the entity	Yes
4	Premises details	No
5	Buyer visit details	--
6	Contact numbers	Yes
7	Name of the person contacted	No
8	Designation of contact person	No
9	Promoter’s background	Yes
10	Date of Birth of Proprietor / Partners / Directors	Yes
11	Pan Card No. of Proprietor / Partners	No
12	Voter Id Card No. of Proprietor / Partners	No
13	Type of business	Yes
14	Line of Business	Yes
15	Export/import details (if applicable)	No
16	No. of employees	No
17	Details of sister concerns	Yes
18	Major suppliers	No
19	Major customers	No
20	Banking Details	Yes
21	Banking facility details	Yes
22	Conduct of the banking account	--
23	Financials, if provided	Yes
24	Capital in the business	Yes
25	Last accounts filed at ROC, if applicable	Yes
26	Turnover of firm for last three years	Yes
27	Reasons for variation <> 20%	--
28	Estimation for coming financial year	No
29	Profitability for last three years	Yes
30	Major shareholders, if available	Yes
31	External Agency Rating, if available	No
32	Litigations that the firm/promoter involved in	--
33	Market information	--
34	Payments terms	No
35	Negative Reporting by Auditors in the Annual Report	No

UNSECURED LOAN

Particulars	As on 31.03.2014	As on 31.03.2013
LONG TERM BORROWING
Deferred payment liabilities	0.770	4.275
Total	0.770	4.275

OPERATIONS

The Company achieved a total net income of Rs. 41,83.700 Million during the year as compared to Rs. 37,52.400 Million in the previous year, representing an income growth of over 11%. The new drug pricing policy (DPCO 2013) was approved and notified by Govt. of India. The said new pricing policy has marginally impacted the Company’s 13 products where the prices were required to be revised downward.

INDEX OF CHARGES

S.No.	Charge ID	Date of Charge Creation/Modification	Charge amount secured	Charge Holder	Address	Service Request Number (SRN)
1	80042579	25/06/2007 *	103,500,000.00	CENTRAL BANK OF INDIA (Lead Bank )	CHANDERMUKHI BUILDING, GROUND FLOOR,, NARIMAN POINT, MUMBAI, Maharashtra - 400021, INDIA	A33765736

*Date of charge modification

FIXED ASSETS

Tangible assets

• Land
• Buildings
• Plant and equipment
• Furniture and fixtures
• Vehicles
• Office equipment

Intangible assets

• Computer software

Patents

CMT REPORT (Corruption, Money Laundering & Terrorism]

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

1] INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

2] Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

3] Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

4] Record on Financial Crime :

Charges or conviction registered against subject: None

5] Records on Violation of Anti-Corruption Laws :

Charges or investigation registered against subject: None

6] Records on Int’l Anti-Money Laundering Laws/Standards :

Charges or investigation registered against subject: None

7] Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

8] Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

9] Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

10] Press Report :

No press reports / filings exists on the subject.

CORPORATE GOVERNANCE

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

CONTRAVENTION

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.63.62
UK Pound	1	Rs.98.51
Euro	1	Rs.69.93

INFORMATION DETAILS

Information Gathered by :	SUP
Analysis Done by :	DIV
Report Prepared by :	ART

SCORE & RATING EXPLANATIONS

SCORE FACTORS	RANGE	POINTS
HISTORY	1~10	7
PAID-UP CAPITAL	1~10	7
OPERATING SCALE	1~10	7
FINANCIAL CONDITION
--BUSINESS SCALE	1~10	7
--PROFITABILITY	1~10	7
--LIQUIDITY	1~10	7
--LEVERAGE	1~10	7
--RESERVES	1~10	8
--CREDIT LINES	1~10	7
--MARGINS	-5~5	-
DEMERIT POINTS
--BANK CHARGES	YES/NO	YES
--LITIGATION	YES/NO	NO
--OTHER ADVERSE INFORMATION	YES/NO	NO
MERIT POINTS
--SOLE DISTRIBUTORSHIP	YES/NO	NO
--EXPORT ACTIVITIES	YES/NO	NO
--AFFILIATION	YES/NO	YES
--LISTED	YES/NO	NO
--OTHER MERIT FACTORS	YES/NO	YES
DEFAULTER
--RBI	YES/NO	NO
--EPF	YES/NO	NO
TOTAL		64

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
--	NB	New Business	--

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.